Climacteric-Like Disorders in Prostate Cancer Patients Treated With LHRH Agonists

Author： Nishimura K.   Yamaguchi Y.   Yamanaka M.   Ichikawa Y.   Nagano S.  

Publisher： Informa Healthcare

ISSN： 1521-0375

Source： Archives of Andrology, Vol.51, Iss.1, 2005-01, pp. : 41-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality of Life in Patients with Prostate Cancer Treated with LH-RH Agonists

By  

Current Urology, Vol. 2, Iss. 1, 2008-08 ,pp. : 30-35

Karger

Access to resources Recommend Favorite

LHRH agonists in prostate cancer: frequency of treatment, serum testosterone measurement and castrate level: consensus opinion from a roundtable discussion

By de Jong Igle Jan   Eaton Alan   Bladou Franck  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1077-1080

Informa Healthcare

Access to resources Recommend Favorite

Comparison of LH-RH Analogue 1-Month Depot and 3-Month Depot by Their Hormone Levels and Pharmacokinetic Profile in Patients with Advanced Prostate Cancer

By  

Urologia Internationalis, Vol. 60, Iss. 1, 1998-03 ,pp. : 9-17

Karger

Access to resources Recommend Favorite

Phase II, randomised, double‐blind, placebo‐controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH‐agonist therapy

By  

BJU INTERNATIONAL, Vol. 1464-4096, Iss. 5, 2015-11 ,pp. : 744-752

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II, randomised, double‐blind, placebo‐controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH‐agonist therapy

By  

BJU INTERNATIONAL, Vol. 116, Iss. 5, 2015-11 ,pp. : 744-752

John Wiley & Sons Inc

Access to resources Recommend Favorite